METHOD OF PREPARING CRYSTAL COMPOUNDS

The present invention relates to a manufacturing method of a crystalline compound, a crystal of the compound manufactured thereby, and a composition comprising same for treating dysuresia. More particularly, the manufacturing method of the crystalline compound uses toluene and a C_4-C_8 ether solven...

Full description

Saved in:
Bibliographic Details
Main Authors YOON, YEO HONG, LIM, JEE WOONG
Format Patent
LanguageEnglish
Korean
Published 17.08.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a manufacturing method of a crystalline compound, a crystal of the compound manufactured thereby, and a composition comprising same for treating dysuresia. More particularly, the manufacturing method of the crystalline compound uses toluene and a C_4-C_8 ether solvent. Thus, the manufactured crystalline compound has a low content of residual solvent harmful to human bodies, and has excellent quality. The crystalline compound is represented by chemical formula 1. 본 발명은 결정성 화합물의 제조방법, 이에 의해 제조된 화합물의 결정 및 이를 포함하는 배뇨장애 치료용 조성물에 관한 것으로, 구체적으로는 톨루엔 및 C-C에테르 용매를 이용하여 결정성 화합물을 제조함으로써, 인체에 유해한 잔류용매 함유량이 낮은 우수한 품질의 결정성 화합물을 제조할 수 있는 제조방법, 이에 의해 제조된 화합물의 결정 및 이를 포함하는 배뇨장애 치료용 조성물에 관한 것이다.
Bibliography:Application Number: KR20150018804